“I am excited to provide patients with options for treatment from an evolving field of standard-of-care therapies and opportunities to participate in clinical trials. I believe in making treatment better for tomorrow.”
Dr. Lambird is board certified in internal medicine, hematology and oncology (blood disorders and cancer). He has a special interest in blood and marrow transplantation, chemotherapy and cellular therapies for patients with multiple myeloma and other blood cancers, such as acute leukemias and myelodysplastic syndrome.
He is an assistant professor of hematology and oncology at Wake Forest University School of Medicine.
His research interests include the development of novel conditioning regimens for allogeneic stem cell transplant and the reduction of relapse after stem cell transplant for myeloid diseases. He has received an American Cancer Society Institutional Research Grant Pilot Project Award and an Atrium Health Wake Forest Baptist Comprehensive Cancer Care Clinical Trial Boot Camp Funding Award.
Additionally, he was named a Research Fellow of the Year and held positions on the Cancer Center Scientific Review and Monitoring and Peer Education committees at the University of Florida.
Dr. Lambird completed his undergraduate studies at the University of Missouri. He received his medical degree and a master’s degree in business administration (MBA) at Wake Forest University. Dr. Lambird completed residency and a fellowship in hematology-oncology at the University of Florida.
Outside of work, he enjoys spending time with his wife and children, hiking and making things in his home workshop.